TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart drug safety check completed in small indian study
Disease control CompletedThis study aimed to monitor the safety of the drug Tafamidis (VyndaMx®) in Indian patients with a specific heart condition called ATTR-CM, where a protein clumps in the heart. Six adult patients who were already prescribed the drug participated, and researchers tracked any side e…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Sponsor: Pfizer • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Heart Drug's Real-World impact studied in korean patients
Disease control CompletedThis study looked at how well the medicine Tafamidis 61mg worked for Korean patients with a specific heart muscle disease called ATTR-CM. It observed 13 patients who were already prescribed this medicine in real-world settings, not as part of a controlled trial. The goal was to c…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOMYOPATHY
Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC